Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2015, Article ID 478789, 5 pages
http://dx.doi.org/10.1155/2015/478789
Case Report

Pulmonary Mucormycosis in a Patient with Systemic Lupus Erythematosus: A Diagnostic and Treatment Challenge

1Division of Gastroenterology, Department of Internal Medicine, Nantou Hospital, Ministry of Health and Welfare, No. 478, Fuxing Road, Nantou City, Nantou County 540, Taiwan
2Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chiu General Hospital, No. 137, Chenggong First Road, Lingya District, Kaohsiung 802, Taiwan
3Department of Family and Community Medicine, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo North Road, Taichung 402, Taiwan
4School of Medicine, Chung Shan Medical University, No. 110, Section 1, Jianguo North Road, Taichung 402, Taiwan
5Institute of Medicine and School of Medicine, Chung Shan Medical University, No. 110, Section 1, Jianguo North Road, Taichung 402, Taiwan
6Division of Allergy, Immunology, Rheumatology, Department of Internal Medicine, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo North Road, Taichung 402, Taiwan
7Division of Infectious Diseases, Department of Internal Medicine, Chung Shan Medical University Hospital, No. 110, Section 1, Jianguo North Road, Taichung 402, Taiwan
8Department of Family Medicine, Taichung Hospital, Ministry of Health and Welfare, No. 199, Section 1, Sanmin Road, Taichung 403, Taiwan

Received 24 February 2015; Revised 1 June 2015; Accepted 3 June 2015

Academic Editor: Larry M. Bush

Copyright © 2015 Hung-Chang Hung et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Spellberg, J. Edwards Jr., and A. Ibrahim, “Novel perspectives on mucormycosis: pathophysiology, presentation, and management,” Clinical Microbiology Reviews, vol. 18, no. 3, pp. 556–569, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Hibbett, M. Binder, J. F. Bischoff et al., “A higher-level phylogenetic classification of the Fungi,” Mycological Research, vol. 111, no. 5, pp. 509–547, 2007. View at Publisher · View at Google Scholar
  3. M. M. Roden, T. E. Zaoutis, W. L. Buchanan et al., “Epidemiology and outcome of zygomycosis: a review of 929 reported cases,” Clinical Infectious Diseases, vol. 41, no. 5, pp. 634–653, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Sharma, S. Kumar, A. K. Singh et al., “Feasibility and outcome of CT-guided lung biopsy in patients with hematological diseases and suspected fungal pneumonia,” Journal of Infection in Developing Countries, vol. 7, no. 10, pp. 748–752, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y.-C. Fan, W.-G. Li, M.-H. Zheng, W. Gao, Y.-Y. Zhang, and L.-J. Song, “Invasive fungal infection in patients with systemic lupus erythematosus: experience from a single institute of Northern China,” Gene, vol. 506, no. 1, pp. 184–187, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J.-A. H. van Burik, R. S. Hare, H. F. Solomon, M. L. Corrado, and D. P. Kontoyiannis, “Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases,” Clinical Infectious Diseases, vol. 42, no. 7, pp. e61–e65, 2006. View at Google Scholar
  7. R. Y. Hachem, A. A. Langston, J. R. Graybill et al., “Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 6, pp. 1386–1391, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. H.-Y. Sun and N. Singh, “Mucormycosis: its contemporary face and management strategies,” The Lancet Infectious Diseases, vol. 11, no. 4, pp. 301–311, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. U. Martínez-Martínez, D. Herrera-Van Oostdam, S. Román-Acosta, M. Magaña-Aquino, L. Baranda-Cándido, and C. Abud-Mendoza, “Invasive fungal infections in patients with systemic lupus erythematosus,” The Journal of Rheumatology, vol. 39, no. 9, pp. 1814–1818, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G.-L. Chen, Y. Chen, C.-Q. Zhu, C.-D. Yang, and S. Ye, “Invasive fungal infection in Chinese patients with systemic lupus erythematosus,” Clinical Rheumatology, vol. 31, no. 7, pp. 1087–1091, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C.-T. Weng, N.-Y. Lee, M.-F. Liu et al., “A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan,” Lupus, vol. 19, no. 10, pp. 1204–1209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. J. Walsh, M. N. Gamaletsou, M. R. McGinnis, R. T. Hayden, and D. P. Kontoyiannis, “Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis),” Clinical Infectious Diseases, vol. 54, supplement 1, pp. S55–S60, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. T. T. Hansel, H. Kropshofer, T. Singer, J. A. Mitchell, and A. J. T. George, “The safety and side effects of monoclonal antibodies,” Nature Reviews Drug Discovery, vol. 9, no. 4, pp. 325–338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kelesidis, G. Daikos, D. Boumpas, and S. Tsiodras, “Does rituximab increase the incidence of infectious complications? A narrative review,” International Journal of Infectious Diseases, vol. 15, no. 1, pp. e2–e16, 2011. View at Publisher · View at Google Scholar · View at Scopus